Revolution Medicines, Inc. RVMD Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s operating cash flow?
- Revolution Medicines, Inc. (RVMD) reported operating cash flow of -$354.17M in Q1 2026.
- How has Revolution Medicines, Inc.'s operating cash flow changed year-over-year?
- Revolution Medicines, Inc.'s operating cash flow decreased by 82.2% year-over-year, from -$194.44M to -$354.17M.
- What is the long-term trend for Revolution Medicines, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s operating cash flow has grown at a 57.2% compound annual growth rate (CAGR), from -$147.18M to -$897.74M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.